D.E. Shaw & Co’s CytomX Therapeutics CTMX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q2
Sell
-10,811
Closed -$23.6K 3227
2024
Q1
$23.6K Sell
10,811
-766
-7% -$1.67K ﹤0.01% 2920
2023
Q4
$17.9K Sell
11,577
-61,917
-84% -$96K ﹤0.01% 2871
2023
Q3
$94.8K Sell
73,494
-56,966
-44% -$73.5K ﹤0.01% 2671
2023
Q2
$224K Sell
130,460
-170,381
-57% -$293K ﹤0.01% 2585
2023
Q1
$454K Sell
300,841
-317,533
-51% -$479K ﹤0.01% 2551
2022
Q4
$989K Buy
618,374
+128,744
+26% +$206K ﹤0.01% 2434
2022
Q3
$710K Buy
489,630
+242,153
+98% +$351K ﹤0.01% 2708
2022
Q2
$453K Buy
247,477
+77,526
+46% +$142K ﹤0.01% 3082
2022
Q1
$454K Buy
+169,951
New +$454K ﹤0.01% 3256
2021
Q4
Sell
-26,297
Closed -$134K 4018
2021
Q3
$134K Sell
26,297
-163,147
-86% -$831K ﹤0.01% 3339
2021
Q2
$1.2M Sell
189,444
-129,037
-41% -$817K ﹤0.01% 2393
2021
Q1
$2.46M Sell
318,481
-297,518
-48% -$2.3M ﹤0.01% 1743
2020
Q4
$4.04M Buy
615,999
+103,511
+20% +$678K ﹤0.01% 1416
2020
Q3
$3.41M Buy
512,488
+147,391
+40% +$980K ﹤0.01% 1376
2020
Q2
$3.04M Sell
365,097
-157,555
-30% -$1.31M ﹤0.01% 1410
2020
Q1
$4.01M Sell
522,652
-177,449
-25% -$1.36M 0.01% 1171
2019
Q4
$5.82M Buy
700,101
+363,097
+108% +$3.02M 0.01% 1104
2019
Q3
$2.49M Buy
337,004
+4,810
+1% +$35.5K ﹤0.01% 1480
2019
Q2
$3.73M Sell
332,194
-47,560
-13% -$534K ﹤0.01% 1326
2019
Q1
$4.08M Buy
379,754
+246,072
+184% +$2.65M 0.01% 1233
2018
Q4
$2.02M Buy
133,682
+11,365
+9% +$172K ﹤0.01% 1515
2018
Q3
$2.26M Buy
122,317
+14,264
+13% +$264K ﹤0.01% 1481
2018
Q2
$2.47M Buy
108,053
+30,538
+39% +$698K ﹤0.01% 1489
2018
Q1
$2.21M Buy
77,515
+47,034
+154% +$1.34M ﹤0.01% 1460
2017
Q4
$643K Buy
30,481
+17,998
+144% +$380K ﹤0.01% 1988
2017
Q3
$227K Buy
+12,483
New +$227K ﹤0.01% 2312
2016
Q1
Sell
-21,257
Closed -$444K 2592
2015
Q4
$444K Buy
+21,257
New +$444K ﹤0.01% 2114